Bioavailability and Cardiometabolic Effects of Xanthohumol: Evidence from Animal and Human Studies
Abstract: Xanthohumol is the main prenylflavonoid in hops and has been associated with a wide range of health benefits, due to its anti‐inflammatory, anti‐oxidative, and cancer‐preventive properties. Increasing evidence suggests that xanthohumol positively affects biomarkers associated with metabolic syndrome and cardiovascular diseases (CVDs). This review summarizes the effects of xanthohumol supplementation on body weight, lipid and glucose metabolism, systemic inflammation, and redox status. In addition, it provides insights into the pharmacokinetics of xanthohumol intake. Animal studies show that xanthohumol exerts beneficial effects on body weight, lipid profile, glucose metabolism, and other biochemical parameters associated with metabolic syndrome and CVDs. Although in vitro studies are increasingly elucidating the responsible mechanisms, the overall in vivo results are currently inconsistent and quantitatively insufficient. Pharmacokinetic and safety studies confirm that intake of xanthohumol is safe and well tolerated in both animals and humans. However, little is known about the metabolism of xanthohumol in the human body, and even less about its effects on body weight and CVD risk factors. There is an urgent need for studies investigating whether the effects of xanthohumol on body weight and cardiometabolic parameters observe in animal studies are reproducible in humans, and what dosage, formulation, and intervention period are required.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Bioavailability and Cardiometabolic Effects of Xanthohumol: Evidence from Animal and Human Studies ; day:14 ; month:01 ; year:2022 ; extent:16
Molecular nutrition & food research ; (14.01.2022) (gesamt 16)
- Creator
- DOI
-
10.1002/mnfr.202100831
- URN
-
urn:nbn:de:101:1-2022011514201945833193
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Neumann, Hannah F.
- Frank, Jan
- Venturelli, Sascha
- Egert, Sarah
Other Objects (12)
Genetic and epigenetic studies of adiposity and cardiometabolic disease
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
A reexamination of krill oil bioavailability studies
Introduction: Cultural and Literary Animal Studies
Free Cholesterol Bioavailability and Atherosclerosis
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Human-Animal Studies
Principles and perspectives in drug bioavailability
Fluoride bioavailability in saliva and plaque
Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies
Substitution of animal-based with plant-based foods on cardiometabolic health and all-cause mortality: a systematic review and meta-analysis of prospective studies
Genetic and epigenetic studies of adiposity and cardiometabolic disease
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
A reexamination of krill oil bioavailability studies
Introduction: Cultural and Literary Animal Studies
Free Cholesterol Bioavailability and Atherosclerosis
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Human-Animal Studies
Principles and perspectives in drug bioavailability
Fluoride bioavailability in saliva and plaque
Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies
Substitution of animal-based with plant-based foods on cardiometabolic health and all-cause mortality: a systematic review and meta-analysis of prospective studies
Genetic and epigenetic studies of adiposity and cardiometabolic disease
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
A reexamination of krill oil bioavailability studies
Introduction: Cultural and Literary Animal Studies
Free Cholesterol Bioavailability and Atherosclerosis
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Human-Animal Studies
Principles and perspectives in drug bioavailability
Fluoride bioavailability in saliva and plaque
Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies